31.400
+0,00%
2026-10-19
Fundamental Analysis
63 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +3.4% | +47.4% | 2 / 3 | +0.4% | +1.66 pp | +1.68 pp | +23.6% | 0.00 | 10.58 | 237 | +0,4% | 141 | +3,4% | 10.58 | 11.78 | −10,2% |
| Pts | 0 | 12 | 8 | 0 | 8 | 8 | 12 | 12 | 8 | |||||||
Valuation annotation:Price: 31.400 (close price on 2026-10-19)EPS (TTM): 2.967
Financial charts
1.Revenue & growth
VND bn237Q3/26
1.Revenue & growth
VND bn237Q3/26
2.Profit & growth
VND bn141Q3/26
3.Profit mix (Penman)
VND bn348Q3/26
4.Margins & cost structure
%58.8%Q3/26
5.Returns & cash cycle
% · days27.3%Q3/26
6.Earnings quality & cash
VND bn248Q3/26
7.Asset structure
VND bn1.353Q3/26
8.Funding & debt health
VND bn · times1.353Q3/26
9.Revenue backlog
VND bn0,00Q3/26
10.Valuation
times · %10,6×Q3/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.398Q3/26
Adjusted EPS growth, latest quarter
3.4%
Average adjusted EPS growth, 3 quarters
47.4%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
Share history could not be reconciled
Source: vnstockData through Q3/26